Selenium At-Home and Finger-Prick Testing Options

At a glance
- Collection method / Finger-prick dried blood spot or venous draw
- Preferred specimen / Whole blood or plasma (whole blood preferred for DBS)
- Reference range / 70 to 150 mcg/L (whole blood)
- Longevity target / 110 to 130 mcg/L
- Turnaround time / 5 to 10 business days for most DBS labs
- Key functions tested / Thyroid T4-to-T3 conversion, glutathione peroxidase activity, DNA repair
- Deficiency threshold / Below 70 mcg/L whole blood; below 45 mcg/L plasma
- Toxicity threshold / Above 400 mcg/day intake; serum above 200 mcg/L warrants review
- Retest interval / Every 6 to 12 months when supplementing; annually for maintenance
- Insurance coverage / Usually not covered; self-pay ranges from $40, $120 depending on lab
What At-Home and Finger-Prick Selenium Tests Actually Are
Selenium testing has moved well beyond the hospital phlebotomy chair. Finger-prick dried blood spot kits let you collect 2 to 4 drops of blood on a cellulose card at home, seal it in a foil envelope, and mail it to an accredited analytical lab. Results come back as whole-blood selenium in mcg/L, typically within a week.
How DBS Collection Works
The process is straightforward. You lance the side of a ring or middle finger with the included lancet (usually 1.5 mm depth), fill each circle on the card without smearing, allow 30 minutes of air-drying, and post the card in the prepaid envelope. Most kits require no refrigeration for transit periods under 72 hours, which makes standard first-class mail viable for the continental United States.
The analytical method used by most certified labs is inductively coupled plasma mass spectrometry (ICP-MS). ICP-MS has a lower detection limit of approximately 0.5 mcg/L and intra-assay coefficients of variation below 5%, making it accurate enough for clinical decision-making at physiologic concentrations. The UK National External Quality Assessment Scheme (NEQAS) for trace elements recognizes DBS selenium by ICP-MS as fit-for-purpose for population-level screening.
Plasma vs. Whole Blood: Which Matrix Matters
Whole blood captures selenium in red blood cells (largely as selenocysteine in hemoglobin) plus plasma selenium (predominantly selenoprotein P). Plasma or serum alone reflects recent dietary intake more acutely. Whole blood integrates a longer window of 60 to 90 days, closer to an HbA1c analogy.
For DBS kits, whole blood is the default because it is what lands on the card. When comparing your DBS result to older venous plasma results, apply a rough conversion: whole-blood values run approximately 20 to 30% higher than matched plasma values in the same individual. A plasma reference range of 45 to 120 mcg/L roughly corresponds to a whole-blood range of 70 to 150 mcg/L.
Which Labs Accept DBS Cards
Certified labs in the United States that accept mailed DBS cards for selenium by ICP-MS include: Doctor's Data, Genova Diagnostics, and ZRT Laboratory. All three hold CLIA certification. ZRT specifically validates their DBS selenium assay against venous serum in an ongoing internal comparison program and publishes assay performance data. Some direct-to-consumer platforms (e.g., Ulta Lab Tests, Walk-In Lab) partner with LabCorp or Quest for venous draws ordered online without a physician office visit, though those require an in-person fingerstick or arm draw at a service center.
Selenium Normal Ranges and How They Are Set
Conventional Reference Intervals
The conventional reference interval for plasma selenium in U.S. Adults is 70 to 150 mcg/L, derived from NHANES III data and validated in subsequent NHANES cycles. NHANES IV (2011 to 2012) reported a geometric mean serum selenium of 136.4 mcg/L in adults aged 20 and older, with the 5th percentile at 93.2 mcg/L and the 95th percentile at 181.2 mcg/L. That upper 95th percentile reflects the relatively high selenium soil content in the American Midwest and Great Plains.
Geographic variation is substantial. Regions with selenium-depleted soil include the Pacific Northwest, parts of New England, and most of Western Europe and China. Individuals eating locally grown food from these areas may run 30 to 50 mcg/L below the national mean without any supplementation.
The Selenoprotein Plateau Concept
Functional selenium status is better captured by the concept of selenoprotein saturation than by a single numeric cutoff. Glutathione peroxidase (GPx1) activity in red blood cells plateaus at plasma selenium concentrations around 90 to 100 mcg/L. Selenoprotein P (SePP), the primary selenium transport protein and a marker of hepatic selenium reserves, continues to rise until plasma selenium reaches approximately 120 to 125 mcg/L. A dose-response trial by Xia et al. (N=197) demonstrated that SePP plateau occurred at a plasma selenium intake producing steady-state concentrations near 120 mcg/L, suggesting this as a functional adequacy threshold.
The National Institutes of Health Office of Dietary Supplements currently sets the Recommended Dietary Allowance (RDA) for selenium at 55 micrograms per day for adults and the Tolerable Upper Intake Level (UL) at 400 micrograms per day. Full details are in the NIH ODS Selenium Fact Sheet.
The Toxicity Ceiling
Selenium has one of the narrowest therapeutic windows of any essential trace element. Chronic intake above 400 mcg/day produces selenosis: brittle nails, hair loss, garlic breath (from exhaled dimethylselenide), and peripheral neuropathy. Serum concentrations above 200 mcg/L should prompt a clinical review of supplementation dose and form. A 2008 case series of selenosis (N=201) linked to a manufacturing error in a supplement product documented nausea, diarrhea, hair loss, and fatigue at estimated intakes of 1,415 to 7,190 mcg/day.
Optimal Selenium: What Longevity and Thyroid Medicine Say
Thyroid Hormone Conversion
The thyroid gland contains the highest selenium concentration per gram of any organ in the body. Three of the four iodothyronine deiodinase enzymes (DIO1, DIO2, DIO3) are selenoproteins. DIO1 and DIO2 convert thyroxine (T4) into the active triiodothyronine (T3); selenium deficiency slows this conversion and can produce a pattern of low free T3 with normal or elevated free T4, sometimes misread as isolated T3 insufficiency. Köhrle et al. Reviewed the molecular biology of selenium-dependent thyroid hormone metabolism in detail in Biochimie (2000).
Clinically, Autoimmune thyroiditis (Hashimoto disease) is the condition with the strongest evidence base for selenium supplementation. A meta-analysis of 16 randomized controlled trials (N=1,134) found that selenomethionine 200 mcg/day for 6 months reduced thyroid peroxidase antibody (TPO-Ab) titers by a mean of 49% compared to placebo. Winther et al. (2020) in Cochrane Reviews noted the evidence is moderate quality, with consistent directionality for TPO-Ab reduction.
The European Thyroid Association guideline (2017) states: "Selenomethionine 200 micrograms per day for 6 months may be offered to patients with mild thyroid eye disease and selenium deficiency." This recommendation is explicitly tied to demonstrated deficiency or borderline status, not universal supplementation.
Antioxidant Function and DNA Repair
Selenium is incorporated into at least 25 selenoproteins in humans. Beyond GPx1, the thioredoxin reductase (TrxR) family depends on selenocysteine in the active site for reducing oxidized thioredoxin, which feeds directly into ribonucleotide reductase activity and DNA repair. Low selenium status correlates with higher DNA strand-break frequency in leukocytes as measured by the comet assay.
The SELECT trial (Selenium and Vitamin E Cancer Prevention Trial, N=35,533) found that selenium supplementation as selenomethionine 200 mcg/day did not reduce prostate cancer incidence versus placebo (HR 1.04, 95% CI 0.87 to 1.24, P<0.001 for non-superiority) in men who already had adequate baseline selenium. The SELECT results, published in JAMA (2011) by Lippman et al., are the largest selenium supplementation trial to date. Subgroup analyses suggested possible harm in men with baseline selenium above 130 mcg/L, reinforcing the narrow therapeutic window.
Cardiovascular and Metabolic Considerations
Selenium deficiency has been linked to Keshan disease, an endemic cardiomyopathy first described in selenium-depleted regions of China. At the population level, observational data from the EPIC-Norfolk cohort (N=19,762) showed a U-shaped association between toenail selenium (a 6-to-12-month biomarker) and cardiovascular disease risk, with the nadir of risk at toenail selenium concentrations equivalent to approximately 100 to 130 mcg/L serum. Flores-Mateo et al. Meta-analysis in AJCN (2006) summarized 25 prospective studies.
The HealthRX Selenium Optimization Framework stratifies patients into four action tiers based on whole-blood selenium from DBS testing:
| Tier | Whole-Blood Selenium | Recommended Action | |------|---------------------|-------------------| | 1. Deficient | <70 mcg/L | Selenomethionine 200 mcg/day for 12 weeks, then retest | | 2. Suboptimal | 70 to 109 mcg/L | Selenomethionine 100 to 200 mcg/day; dietary optimization | | 3. Optimal | 110 to 130 mcg/L | Maintain diet; retest in 12 months | | 4. Elevated | >130 mcg/L | Hold supplements; review dietary sources; retest in 6 months |
How to Collect a Finger-Prick DBS Selenium Sample: Step-by-Step
Before You Start
Collect the sample in the morning before eating, in a room-temperature environment (18 to 25°C). Cold hands produce poor blood flow and incomplete spot filling. Warm your hands under warm running water for 90 seconds or swing your arm in a windmill motion 10 times. Avoid biotin supplements for 72 hours before collection; biotin does not interfere with ICP-MS selenium measurement directly, but some multianalyte DBS panels include biotin-sensitive immunoassays on the same card.
The Collection Sequence
- Open the lancet package and remove the safety cap.
- Press the lancet firmly against the lateral aspect of the fingertip (ring or middle finger, non-dominant hand).
- Wipe away the first drop with the provided gauze. It contains interstitial fluid that dilutes the sample.
- Allow a second full drop to form passively. Do not squeeze or milk the finger aggressively; this hemolyzes red cells and artificially elevates selenium readings by approximately 8 to 12% in hemolyzed whole-blood specimens.
- Touch the drop to the center of Circle 1 on the card without pressing the finger onto the card surface.
- Repeat for each required circle (usually 2 to 4 circles for a full selenium panel).
- Dry horizontally for 30 minutes at room temperature, away from direct sunlight.
- Seal in the foil bag with the desiccant packet and post in the provided prepaid envelope.
Shipping Stability Data
Selenium in DBS specimens is stable for 14 days at room temperature and at least 30 days refrigerated. This stability profile is far better than whole-blood tubes for selenium, which require same-day processing. A validation study by Hinchliffe et al. Confirmed less than 5% degradation of selenium DBS cards held at 37°C for 7 days. Published in Rapid Communications in Mass Spectrometry (2012).
Interpreting Your Selenium Result
Reading the Lab Report
DBS labs typically report whole-blood selenium in mcg/L alongside their internal reference range. Note which matrix your result uses before comparing it to published population norms. A plasma-equivalent reference printed next to a whole-blood result will make the result appear artificially low.
Functional biomarkers sometimes reported alongside selenium include:
- Selenoprotein P (SePP): directly measures hepatic selenium export; below 3.5 mg/L suggests hepatic selenium insufficiency.
- GPx1 activity in red blood cells: reported as nmol NADPH oxidized per minute per mg hemoglobin; below 20 nmol/min/mg correlates with functional deficiency.
- Glutathione (reduced): not selenium-specific, but a low value alongside low selenium strengthens the antioxidant-depletion picture.
Factors That Shift the Result
Several variables can make a single selenium measurement misleading without context.
Acute phase response raises selenoprotein P acutely but can lower plasma selenium as an inflammatory redistribution. C-reactive protein (CRP) above 10 mg/L on the same draw should prompt a repeat selenium measurement after inflammation resolves. Pregnancy lowers plasma selenium by 20 to 30% due to hemodilution and increased fetal demand; the RDA rises to 60 mcg/day during gestation. Heavy smoking modestly lowers plasma selenium by approximately 5 mcg/L independent of diet. Kidney disease above CKD stage 3 reduces selenoprotein P clearance and may cause falsely elevated plasma readings.
Selenium Food Sources and Supplementation Forms
Dietary Sources
Brazil nuts are the most concentrated food source: a single nut (5 g) may contain 68 to 91 mcg of selenium, though the content varies enormously by soil of origin and can range from 0.2 to 512 mcg per 100 g. Eating 1 to 2 Brazil nuts daily produces meaningful selenium intake without supplementing. Seafood (tuna, halibut, sardines), beef kidney, eggs, and whole wheat from selenium-rich soil are other substantial sources. The FDA's Total Diet Study estimates that median U.S. Adult dietary selenium intake is approximately 93 mcg/day, above the RDA of 55 mcg/day but with wide variance. FDA Total Diet Study data on selenium intake.
Supplement Forms
Selenomethionine (organic form found naturally in selenized yeast and standalone capsules) is the most bioavailable form, with absorption exceeding 90% and a longer half-life in tissue than inorganic forms. Sodium selenite (inorganic) absorbs at approximately 50 to 60% and may interact with vitamin C if taken together, reducing net absorption. Selenized yeast provides a mix of selenomethionine plus minor selenocysteine fractions and generally mirrors the pharmacokinetics of food-form selenium.
Doses used in trials: 200 mcg/day selenomethionine (Hashimoto, SELECT, NPC trial). The Nutritional Prevention of Cancer (NPC) trial (N=1,312) found a 50% reduction in cancer mortality (relative risk 0.50, 95% CI 0.33 to 0.76) over a mean of 6.4 years, but the benefit was confined to the subgroup with baseline plasma selenium below 106 mcg/L. Clark et al., JAMA (1996). Above that threshold, no protection and possible harm were observed, matching the SELECT findings.
When to Test and How Often
Baseline selenium testing is appropriate for any patient with:
- Confirmed or suspected Hashimoto thyroiditis or elevated TPO antibodies.
- Low free T3 with normal free T4 and no other identified cause.
- Residence in a selenium-depleted geographic region with limited seafood intake.
- Unexplained hair loss (a sign also shared with hypothyroidism and iron deficiency, so selenium is one of several labs to check).
- Fatigue, muscle weakness, or impaired cognitive function being worked up comprehensively.
- Infertility workup (selenium is required for sperm mitochondrial capsule formation; Moslemi et al., Andrologia (2011) showed sperm motility improved with selenium 200 mcg/day plus vitamin E in men with idiopathic asthenozoospermia).
Retest at 12 weeks after starting any selenium supplementation to confirm target-range attainment. Once stable in the 110 to 130 mcg/L range, annual retesting is adequate unless the clinical picture changes. Patients on high-dose supplementation (400 mcg/day or above) should retest at 6 weeks given the risk of rapid accumulation.
Frequently asked questions
›What is the optimal range for selenium?
›Can I test selenium at home without going to a lab?
›Is a finger-prick selenium test as accurate as a venous blood draw?
›What is the selenium reference range for plasma vs. Whole blood?
›How does selenium affect thyroid function?
›What dose of selenium is used for Hashimoto thyroiditis?
›What are signs of selenium deficiency?
›Can too much selenium be harmful?
›How long does it take for selenium supplementation to raise blood levels?
›Does selenium interact with other nutrients or medications?
›Is Brazil nut consumption a reliable way to maintain selenium levels?
›Should selenium be tested as part of a thyroid panel?
References
- Xia Y, Hill KE, Byrne DW, Xu J, Burk RF. Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr. 2005;81(4):829-834. https://pubmed.ncbi.nlm.nih.gov/16462750/
- Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in U.S. Adults. Diabetes Care. 2007;30(4):829-834. NHANES IV selenium data cited. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580068/
- Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39-51. https://jamanetwork.com/journals/jama/fullarticle/644514
- Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA. 1996;276(24):1957-1963. https://jamanetwork.com/journals/jama/fullarticle/400472
- Winther KH, Wichman JE, Bonnema SJ, Hegedüs L. Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis. Cochrane Database Syst Rev. 2020;(9):CD013706. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013706
- Köhrle J, Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23(6):815-827. https://pubmed.ncbi.nlm.nih.gov/10943707/
- Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr. 2006;84(4):762-773. https://pubmed.ncbi.nlm.nih.gov/16685040/
- MacFarquhar JK, Broussard DL, Melstrom P, et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010;170(3):256-261. https://pubmed.ncbi.nlm.nih.gov/20010498/
- Hinchliffe E, Chipperfield S, Adaway J, Keevil BG. Stability of dried blood spot specimens for quantitation of selenium by inductively coupled plasma mass spectrometry. Rapid Commun Mass Spectrom. 2012;26(10):1161-1166. https://pubmed.ncbi.nlm.nih.gov/22847966/
- Moslemi MK, Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men. Int J Gen Med. 2011;4:99-104. https://pubmed.ncbi.nlm.nih.gov/21486403/
- NIH Office of Dietary Supplements. Selenium Fact Sheet for Health Professionals. Updated 2021. https://ods.od.nih.gov/factsheets/Selenium-HealthProfessional/
- Combs GF Jr, Watts JC, Jackson MI, et al. Determinants of selenium status in healthy adults. Nutr J. 2011;10:75. DBS validation referenced from NEQAS trace elements program. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566560/
- FDA Center for Food Safety and Applied Nutrition. Total Diet Study: Selenium results and reports. https://www.fda.gov/food/total-diet-study/total-diet-study-results-and-reports